Research suggests Semax could impact various neurotransmitter programs and market the secretion of hepatocyte development variable, which could contribute to its neuroprotective outcomes in opposition to age-similar deficits.The review contributes to the sphere of neuropharmacology and also the exploration of latest treatment options for cognitive